(S (NP (NP (NNP Cardiovascular) (NN disease)) (-LRB- -LRB-) (NP (NNS CVD)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT a) (VBG leading) (NN cause)) (PP (IN of) (NP (NP (NN death)) (PP (IN in) (NP (NP (DT the) (NN lung) (NN cancer)) (VP (VBG screening) (NP (NN population))))))))) (. .))
(S (NP (NP (NML (NN Chest) (NN CT)) (NNS scans)) (VP (VBN made) (PP (IN in) (NP (NML (NN lung) (NN cancer)) (NN screening))))) (VP (VBP are) (ADJP (JJ suitable) (PP (IN for) (NP (NP (NN identification)) (PP (IN of) (NP (NP (NNS participants)) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (NP (NNS CVD))))))))))) (. .))
(S (NP (NP (VBG Existing) (NNS methods)) (VP (VBG analyzing) (NP (NN CT) (NNS images)) (PP (IN from) (NP (NP (NML (NN lung) (NN cancer)) (NN screening)) (PP (IN for) (NP (NP (NN prediction)) (PP (IN of) (NP (NP (NNS CVD) (NNS events)) (CC or) (NP (NN mortality)))))))))) (VP (VBP use) (NP (NP (VBN engineered) (NNS features)) (VP (VBN extracted) (PP (IN from) (NP (NP (DT the) (NNS images)) (VP (VBN combined) (PP (IN with) (NP (JJ patient) (NN information))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN method)) (SBAR (WHNP (WDT that)) (S (ADVP (RB automatically)) (VP (VBZ predicts) (NP (NML (CD 5) (HYPH -) (NN year)) (JJ cardiovascular) (NN mortality)) (ADVP (RB directly)) (PP (IN from) (NP (NML (NN chest) (NN CT)) (NNS scans))) (PP (IN without) (NP (NP (DT the) (NN need)) (PP (IN for) (S (VP (NN hand) (HYPH -) (VBG crafting) (NP (NN image) (NNS features)))))))))))) (. .))
(S (NP (NP (DT A) (NN set)) (PP (IN of) (NP (NP (CD 1,583) (NNS participants)) (PP (IN of) (NP (DT the) (NNP National) (NNP Lung) (NNP Screening) (NNP Trial)))))) (VP (VBD was) (VP (VBN included) (PRN (-LRB- -LRB-) (NP (NP (CD 1,188) (NNS survivors)) (, ,) (NP (CD 395) (NNS non-survivors))) (-RRB- -RRB-)))) (. .))
(S (S (NP (NP (NML (JJ Low) (HYPH -) (NN dose)) (NML (NN chest) (NN CT)) (NNS images)) (VP (VBN acquired) (PP (IN at) (NP (NN baseline))))) (VP (VBD were) (VP (VBN analyzed)))) (CC and) (S (NP (DT the) (NML (NN follow) (HYPH -) (NN up)) (NN time)) (VP (VBD was) (NP (CD 5) (NNS years)))) (. .))
(S (S (VP (TO To) (VP (VB limit) (NP (DT the) (NN analysis)) (PP (IN to) (NP (DT the) (NN heart) (NN region)))))) (, ,) (NP (DT the) (NN heart)) (VP (VBD was) (ADVP (JJ first)) (VP (VBN localized) (PP (IN by) (NP (NP (PRP$ our) (ADJP (RB previously) (VBN developed)) (NN algorithm)) (PP (IN for) (NP (NP (NN organ) (NN localization)) (VP (VBG exploiting) (NP (JJ convolutional) (JJ neural) (NNS networks))))))))) (. .))
(S (ADVP (RB Thereafter)) (, ,) (NP (DT a) (JJ convolutional) (NN autoencoder)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB encode) (NP (DT the) (VBN identified) (NN heart) (NN region))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (ADJP (VBN based) (PP (IN on) (NP (DT the) (VBN extracted) (NNS encodings)))) (NNS subjects)) (VP (VBD were) (VP (VBN classified) (PP (IN into) (NP (NNS survivors) (CC or) (NNS non-survivors))) (S (VP (VBG using) (NP (DT a) (NN support) (NN vector) (NN machine) (NN classifier)))))) (. .))
(S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (NN method)))) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (CD eight) (NN cross-validation) (NNS experiments))) (PP (IN with) (NP (NP (CD 1,433) (NNS images)) (VP (VBN used) (PP (IN for) (NP (NP (NN training)) (, ,) (NP (NP (CD 50)) (PP (IN for) (NP (NN validation)))) (CC and) (NP (NP (CD 100)) (PP (IN for) (NP (NN testing))))))))))) (. .))
(S (NP (DT The) (NN method)) (VP (VBD achieved) (NP (DT a) (NN performance)) (PP (IN with) (NP (DT an) (NN area))) (PP (IN under) (NP (NP (DT the) (NNP ROC) (NN curve)) (PP (IN of) (NP (CD 0.72)))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN prediction)) (PP (IN of) (NP (NP (JJ cardiovascular) (NN mortality)) (PP (ADVP (RB directly)) (IN from) (NP (NML (JJ low) (HYPH -) (NN dose)) (NN screening) (NML (NN chest) (NN CT)) (NNS scans)))))) (, ,) (PP (IN without) (NP (ADJP (NN hand) (HYPH -) (VBN crafted)) (NNS features))) (, ,) (VP (VBZ is) (ADJP (JJ feasible)) (, ,) (S (VP (VBG allowing) (NP (NP (NN identification)) (PP (IN of) (NP (NNS subjects)))) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (NP (JJ fatal) (NNS CVD) (NNS events))))))))))) (. .))
